Syndax Pharmaceuticals, Inc.

SNDX

$9.66

Name : Syndax Pharmaceuticals, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $869,672,960.00

EPSttm : -2.37

Syndax Pharmaceuticals, Inc.

$9.66

1.79%

$0.17

SNDX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

Margin Of Safety %

Put/Call OI Ratio

0.32

EPS Next Q Diff

0.47

EPS Last/This Y

1.16

EPS This/Next Y

1.34

Price

9.46

Target Price

35.9

Analyst Recom

1.09

Performance Q

-52.07

Upside

-974.1%

Beta

0.49

Ticker: SNDX

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-12	SNDX	9.01	0.16	1.74	29512
2026-10-13	SNDX	13.95	0.16	1.01	29972
2026-10-14	SNDX	13.53	0.17	1.90	31199
2026-10-15	SNDX	13.65	0.15	1.46	30892
2026-10-16	SNDX	12.91	0.16	1.15	31204
2026-10-19	SNDX	13.1	0.19	0.58	24094
2026-10-20	SNDX	13.24	0.19	0.41	24393
2026-10-21	SNDX	13.15	0.19	0.00	24679
2026-10-22	SNDX	13.56	0.19	0.37	24693
2026-10-23	SNDX	13.39	0.19	1.24	24841
2026-10-26	SNDX	13.2	0.20	0.49	25090
2026-10-27	SNDX	13.68	0.19	0.19	25121
2026-10-28	SNDX	14.32	0.19	29.94	25264
2026-10-29	SNDX	14.14	0.24	37.77	26362
2026-10-30	SNDX	13.64	0.42	0.40	30247
2026-11-02	SNDX	12.9	0.42	0.89	30357
2026-11-03	SNDX	14.29	0.42	1.03	30611
2026-11-04	SNDX	10.48	0.43	0.90	31426
2026-11-05	SNDX	9.32	0.33	0.69	30481
2026-11-06	SNDX	9.52	0.33	0.07	30525
2026-11-09	SNDX	9.55	0.32	0.16	30940
2026-11-10	SNDX	9.47	0.32	0.47	30729
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-12	SNDX	16.54	32.1	-	-1.95
2026-10-13	SNDX	13.98	32.1	-	-1.95
2026-10-14	SNDX	13.53	32.1	-	-1.98
2026-10-15	SNDX	13.64	32.1	-	-1.98
2026-10-16	SNDX	12.91	30.4	-	-1.98
2026-10-19	SNDX	13.11	30.4	-	-1.98
2026-10-20	SNDX	13.11	30.4	-	-1.98
2026-10-21	SNDX	13.25	30.4	-	-1.98
2026-10-22	SNDX	13.56	30.4	-	-1.98
2026-10-23	SNDX	13.39	30.4	-	-1.98
2026-10-26	SNDX	13.21	30.4	-	-1.98
2026-10-27	SNDX	13.68	30.4	-	-1.98
2026-10-28	SNDX	14.32	30.4	-	-1.98
2026-10-29	SNDX	14.13	30.4	-	-1.98
2026-10-30	SNDX	13.63	31.0	-	-1.94
2026-11-02	SNDX	13.07	31.0	-	-1.94
2026-11-04	SNDX	10.47	31.0	-	-1.95
2026-11-05	SNDX	9.32	31.0	-	-1.95
2026-11-06	SNDX	9.52	38.0	-	-1.91
2026-11-09	SNDX	9.55	38.0	-	-1.91
2026-11-10	SNDX	9.46	38.0	-	-2.13
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-12	SNDX	-1.28	11.26	22.47
2026-10-13	SNDX	-1.28	11.26	22.47
2026-10-14	SNDX	-1.28	11.26	22.47
2026-10-15	SNDX	-1.28	11.26	22.47
2026-10-16	SNDX	-1.28	11.26	22.47
2026-10-19	SNDX	-1.28	11.16	22.47
2026-10-20	SNDX	-1.28	11.16	22.47
2026-10-21	SNDX	-1.28	11.16	22.47
2026-10-22	SNDX	-1.28	11.16	22.47
2026-10-23	SNDX	-1.28	11.16	22.47
2026-10-26	SNDX	-1.28	10.34	22.47
2026-10-27	SNDX	-1.28	10.34	22.18
2026-10-28	SNDX	-1.28	10.34	22.18
2026-10-29	SNDX	-1.28	10.34	22.18
2026-10-30	SNDX	-1.28	10.34	22.18
2026-11-02	SNDX	-1.38	10.39	22.18
2026-11-03	SNDX	-1.38	10.39	22.18
2026-11-05	SNDX	-1.37	10.39	22.00
2026-11-06	SNDX	-1.37	10.39	22.00
2026-11-09	SNDX	-1.37	7.72	22.00
2026-11-10	SNDX	-1.37	7.72	22.00
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.55

Avg. EPS Est. Current Quarter

-0.48

Avg. EPS Est. Next Quarter

-0.08

Insider Transactions

-1.37

Institutional Transactions

7.72

Beta

0.49

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

68.3

Max Drawdown 5-Year %

-69.9

Target Price

35.9

P/E

Forward P/E

PEG

P/S

2.95

P/B

P/Free Cash Flow

EPS

-2.37

Average EPS Est. Cur. Y

-2.13

EPS Next Y. (Est.)

-0.78

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-72.32

Relative Volume

1.25

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

-0.2

EPS 1 30Days Diff

-0.18

EBIT Estimation

◆ SNDX Healthcare

$9.49

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

10/20

Pullback

11/25

Volume

1/15

Valuation

12/20

TP/AR

2/10

Options

5/10

RSI

25.8

Range 1M

Sup Dist

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

11/25

Growth

23/30

Estimates

0/20

Inst/Vol

7/15

Options

9/10

EPS Yr

34.7%

EPS NY

54.2%

52W%

1.4%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +278.3% upside

Quality

6/30

Valuation

16/30

Growth

17/25

Stability

9/10

LT Trend

3/5

Upside

+278.3%

Quality

SNDX — P/E HistoricalBiotechnology

Syndax Pharmaceuticals, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 298

Syndax Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidate includes Revuforj (revumenib), a menin inhibitor for the treatment of relapsed or refractory R/R acute leukemia; and Niktimvo (axatilimab-csfr), a colony stimulating factor-1 receptor blocking antibody to treat chronic graft-versus-host disease. The company is also developing revumenib for the treatment of R/R acute myeloid leukemia (AML) with a nucleophosmin 1 mutation (mNPM1) and in combination with standard-of-care agents in mNPM1 AML or KMT2Ar acute leukemia, as well as for metastatic colorectal cancer; axatilimab to treat idiopathic pulmonary fibrosis; and Entinostat, a Class 1 HDAC inhibitor. It has an agreement with Eddingpharm International Company Limited for licensing, development, and commercialization of Entinostat. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in New York, New York.

SNDX

Latest News

—

Caricamento notizie per SNDX…

stock quote shares SNDX – Syndax Pharmaceuticals, Inc. Stock Price stock today

news today SNDX – Syndax Pharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch SNDX – Syndax Pharmaceuticals, Inc. yahoo finance google finance

stock history SNDX – Syndax Pharmaceuticals, Inc. invest stock market

stock prices SNDX premarket after hours

ticker SNDX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: SNDX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y